112 research outputs found

    Sulfur Tolerance of Selective Partial Oxidation of NO to NO2 in a Plasma

    Full text link
    Several catalytic aftertreatment technologies rely on the conversion of NO to NO2 to achieve efficient reduction of NOx and particulates in diesel exhaust. These technologies include the use of selective catalytic reduction of NOx with hydrocarbons, NOx adsorption, and continuously regenerated particulate trapping. These technologies require low sulfur fuel because the catalyst component that is active in converting NO to NO2 is also active in converting SO2 to SO3 . The SO3 leads t o increase in particulates and/or poison active sites on the catalyst. A non-thermal plasma can be used for the selective partial oxidation of NO to NO2 in the gas-phase under diesel engine exhaust conditions. This paper discusses how a non-thermal plasma can efficiently oxidize NO to NO2 without oxidizing SO2 to SO3

    The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

    Get PDF
    BACKGROUND: Apo2L/TRAIL has considerable promise for cancer therapy based on the fact that this member of the tumor necrosis factor family induces apoptosis in the majority of malignant cells, while normal cells are more resistant. Furthermore, in many cells, when Apo2L/TRAIL is combined with chemotherapy, the effect is synergistic. The majority of this work has been carried out using cell lines. Therefore, investigation of how patient tumors respond to Apo2L/TRAIL can validate and/or complement information obtained from cell lines and prove valuable in the design of future clinical trials. METHODS: We have investigated the Apo2L/TRAIL sensitivity of patient derived pancreatic tumors using a patient tumor xenograft/ SCID mouse model. Mice bearing engrafted tumors were treated with Apo2L/TRAIL, gemcitabine or a combination of both therapies. RESULTS: Patient tumors grown as xenografts exhibited a spectrum of sensitivity to Apo2L/TRAIL. Both Apo2L/TRAIL sensitive and resistant pancreatic tumors were found, as well as tumors that showed heterogeneity of response. Changes in apoptotic signaling molecules in a sensitive tumor were analyzed by Western blot following Apo2L/TRAIL treatment; loss of procaspase 8, Bid and procaspase 3 was observed and correlated with inhibition of tumor growth. However, in a tumor that was highly resistant to killing by Apo2L/TRAIL, although there was a partial loss of procaspase 8 and Bid in response to Apo2L/TRAIL treatment, loss of procaspase 3 was negligible. This resistant tumor also expressed a high level of the anti-apoptotic molecule Bcl-X(L )that, in comparison, was not detected in a sensitive tumor. Importantly, in the majority of these tumors, addition of gemcitabine to Apo2L/TRAIL resulted in a greater anti-tumor effect than either therapy used alone. CONCLUSION: These data suggest that in a clinical setting we will see heterogeneity in the response of patients' tumors to Apo2L/TRAIL, including tumors that are highly sensitive as well as those that are resistant. While much more work is needed to understand the molecular basis for this heterogeneity, it is very encouraging, that Apo2L/TRAIL in combination with gemcitabine increased therapeutic efficacy in almost every case and therefore may be a highly effective strategy for controlling human pancreatic cancer validating and expanding upon what has been reported for cell lines

    Tabletop X-ray Lasers

    Get PDF
    Details of schemes for two tabletop size x‐ray lasers that require a high‐intensity short‐pulse driving laser are discussed. The first is based on rapid recombination following optical‐field ionization. Analytical and numerical calculations of the output properties are presented. Propagation in the confocal geometry is discussed and a solution for x‐ray lasing in Li‐like N at 247 Å is described. Since the calculated gain coefficient depends strongly on the electron temperature, the methods of calculating electron heating following field ionization are discussed. Recent experiments aimed at demonstrating lasing in H‐like Li at 135 Å are discussed along with modeling results. The second x‐ray laser scheme is based on the population inversion obtained during inner‐shell photoionization by hard x rays. This approach has significantly higher‐energy requirements, but lasing occurs at very short wavelengths (λ ≤ 15 Å). Experiments that are possible with existing lasers are discussed

    EUV spectra of highly-charged ions W54+^{54+}-W63+^{63+} relevant to ITER diagnostics

    Full text link
    We report the first measurements and detailed analysis of extreme ultraviolet (EUV) spectra (4 nm to 20 nm) of highly-charged tungsten ions W54+^{54+} to W63+^{63+} obtained with an electron beam ion trap (EBIT). Collisional-radiative modelling is used to identify strong electric-dipole and magnetic-dipole transitions in all ionization stages. These lines can be used for impurity transport studies and temperature diagnostics in fusion reactors, such as ITER. Identifications of prominent lines from several W ions were confirmed by measurement of isoelectronic EUV spectra of Hf, Ta, and Au. We also discuss the importance of charge exchange recombination for correct description of ionization balance in the EBIT plasma.Comment: 11 pages, 4 figure
    corecore